International Urology and Nephrology

, Volume 42, Issue 1, pp 73–79

Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancer

  • Toshifumi Kurahashi
  • Hideaki Miyake
  • Junya Furukawa
  • Masafumi Kumano
  • Atsushi Takenaka
  • Masato Fujisawa
Urology - Original Paper



The objective of this study was to investigate and characterize the clinicopathological features of incidentally detected prostate cancer in radical cystoprostatectomy specimens from Japanese men with bladder cancer.

Materials and methods

We reviewed the pathological reports of 251 male patients who underwent radical cystoprostatectomy for bladder cancer at our institution and identified men with incidentally detected prostate cancer in these specimens. Clinicopathological data of patients with incidental prostate cancer in cystoprostatectomy specimens (group A) were compared with those of 193 patients with clinically detected prostate cancer who underwent radical prostatectomy (group B). Immunohistochemical staining was also performed to measure the expression levels of Ki-67, p53 and androgen receptor (AR) proteins in specimens from both groups A and B.


In this series, a total of 31 patients (12.3%; group A) were incidentally diagnosed as having prostate cancer in radical cystoprostatectomy specimens. Clinically significant cancer, defined as any tumor greater than 0.5 cc according to the report by Stamy et al. (Cancer 71:933–938, 1993) was detected in 9 (29.0%) in group A and 170 (88.1%) in group B. Mean age in group A was significantly older than that in group B, while despite the lack of significant difference in the incidence of seminal vesicle invasion between these two groups, other parameters in group A were significantly more favorable than those in group B, including serum prostate-specific antigen, pathological stage, Gleason score, perineural invasion and capsular penetration. None of the patients in group A had biochemical recurrence (median observation period, 82 months); however, biochemical recurrence occurred in 41 (21.2%) in group B (median observation period, 46 months). Furthermore, immunohistochemical study demonstrated the significantly greater expression of Ki-67, p53 and AR proteins in group B than in group A.


Clinicopathological features of incidentally detected prostate cancer are markedly more favorable than those of clinically detected prostate cancer, which may reflect less aggressive biological phenotypes of incidental prostate cancer arising in Japanese men.


Incidental prostate cancer Radical cystoprostatectomy Radical prostatectomy Immunohistochemical staining 


  1. 1.
    Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJU Int 90:174–184. doi:10.1046/j.1464-410X.2002.02823.x CrossRefPubMedGoogle Scholar
  2. 2.
    Scardino PT, Weaver R, Hudson MA (1992) Early detection of prostate cancer. Hum Pathol 23:211–222. doi:10.1016/0046-8177(92)90102-9 CrossRefPubMedGoogle Scholar
  3. 3.
    Abbas F, Hochberg D, Civantos F, Soloway M (1996) Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 30:322–326PubMedGoogle Scholar
  4. 4.
    Montie JE, Wood DP Jr, Ponte JE, Boyett JM, Levin HS (1989) Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63:381–385. doi:10.1002/1097-0142(19890115)63:2<381::AID-CNCR2820630230>3.0.CO;2-O CrossRefPubMedGoogle Scholar
  5. 5.
    Pritchett TR, Moreno J, Warner NE, Lieskovsky G, Nichols PW, Cook BA, Skinner DG (1988) Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol 139:1214–1216PubMedGoogle Scholar
  6. 6.
    Aydin O, Cosar EF, Varinli S, Bugdatci R, Tansung Z (1999) Prostatic intraepithelial neoplasia in prostate specimens: frequency, significance and relationship to the sampling of the specimen (a retrospective study of 121 cases). Int Urol Nephrol 31:687–697. doi:10.1023/A:1007120907921 CrossRefPubMedGoogle Scholar
  7. 7.
    Moutzouris G, Barbatis C, Plastiras D, Mertziotis N, Katsifotis C, Presvelos V, Theodorou C (1999) Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol 33:27–30PubMedGoogle Scholar
  8. 8.
    Conrad S, Hautmann SH, Henke RP, Erbersdobler A, Simon J, Straub M, Graefen M, Hautmann RE, Huland H (2001) Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol 39:25–29. doi:10.1159/000052579 CrossRefPubMedGoogle Scholar
  9. 9.
    Cindolo L, Benincasa G, Autorino R, Domizio S, de Rosa G, Testa G, D’Armiento M, Altieri V (2001) Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep 8:269–271PubMedGoogle Scholar
  10. 10.
    Prange W, Erbersdobler A, Hammerer P, Graefen M, Hautmann SH, Hautmann RE, Huland H, Henke RP (2001) High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol 39:30–31. doi:10.1159/000052580 CrossRefPubMedGoogle Scholar
  11. 11.
    Ward JF, Bartsch G, Sebo TJ, Pinggerra GM, Blute ML, Zincke H (2004) Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0–2 ng/ml) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol 22:40–47. doi:10.1016/S1078-1439(03)00093-0 PubMedGoogle Scholar
  12. 12.
    Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB (2004) Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171:646–651. doi:10.1097/01.ju.0000107380.40481.bc CrossRefPubMedGoogle Scholar
  13. 13.
    Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez Beltran A, Bostwick DG (2005) Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 36:646–654. doi:10.1016/j.humpath.2005.03.018 CrossRefPubMedGoogle Scholar
  14. 14.
    Ruffion A, Manel A, Massoud W, Decaussin M, Berger N, Paparel P, Morel-Journel N, Lopez JG, Champetier D, Devonec M, Perrin P (2005) Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 65:703–707. doi:10.1016/j.urology.2004.10.076 CrossRefPubMedGoogle Scholar
  15. 15.
    Delongchamps NB, Mao K, Theng H, Zerbib M, Debré B, Peyromaure M (2005) Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur Urol 48:946–950. doi:10.1016/j.eururo.2005.07.008 CrossRefPubMedGoogle Scholar
  16. 16.
    Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR (2005) Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int 75:213–216. doi:10.1159/000087796 CrossRefPubMedGoogle Scholar
  17. 17.
    Lee SH, Chang PL, Chen SM, Sun GH, Chen CL, Shen BY, Wu YS, Tsui KH (2006) Synchronous primary carcinomas of the bladder and prostate. Asian J Urol 8:357–359Google Scholar
  18. 18.
    Rocco B, de Cobelli O, Leon ME, Ferruti M, Mastropasqua MG, Matei DV, Gazzano G, Verweij F, Scardino E, Musi G, Djavan B, Rocco F (2006) Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol 49:827–833. doi:10.1016/j.eururo.2005.12.021 CrossRefPubMedGoogle Scholar
  19. 19.
    Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T (2007) Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 99:554–558. doi:10.1111/j.1464-410X.2006.06660.x CrossRefPubMedGoogle Scholar
  20. 20.
    Abdelhady M, Abusamra A, Pautler SE, Chin L, Izawa JI (2007) Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int 99:326–329. doi:10.1111/j.1464-410X.2006.06558.x CrossRefPubMedGoogle Scholar
  21. 21.
    Watanabe M, Nakayama T, Shiraishi T, Stemmermann GN, Yatani R (2000) Comparative studies of prostate cancer in Japan versus the United States. A review. Urol Oncol 5:274–283. doi:10.1016/S1078-1439(00)00092-2 CrossRefPubMedGoogle Scholar
  22. 22.
    Inoue T, Segawa T, Shiraishi T, Yoshida T, Toda Y, Yamada T, Kinukawa N, Kinoshita H, Kamoto T, Ogawa O (2005) Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population. Urology 66:332–337. doi:10.1016/j.urology.2005.02.028 CrossRefPubMedGoogle Scholar
  23. 23.
    Sakai I, Harada K, Hara I, Eto H, Miyake H (2005) A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 96:528–532. doi:10.1111/j.1464-410X.2005.05678.x CrossRefPubMedGoogle Scholar
  24. 24.
    Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71:933–938. doi:10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L CrossRefPubMedGoogle Scholar
  25. 25.
    Kurahashi T, Muramaki M, Yamanaka K, Hara I, Miyake H (2005) Expression of the secreted form of clustering protein in renal cell carcinoma as a predictor of disease extension. BJU Int 96:895–899. doi:10.1111/j.1464-410X.2005.05733.x CrossRefPubMedGoogle Scholar
  26. 26.
    Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L (2005) Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer 113:619–628. doi:10.1002/ijc.20615 CrossRefPubMedGoogle Scholar
  27. 27.
    Miyake H, Muramaki M, Kurahashi T, Takenaka A, Fujisawa M (2009) Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Urol Oncol (in press)Google Scholar

Copyright information

© Springer Science+Business Media, B.V. 2009

Authors and Affiliations

  • Toshifumi Kurahashi
    • 1
  • Hideaki Miyake
    • 1
  • Junya Furukawa
    • 1
  • Masafumi Kumano
    • 1
  • Atsushi Takenaka
    • 1
  • Masato Fujisawa
    • 1
  1. 1.Division of UrologyKobe University Graduate School of MedicineChuo-ku, KobeJapan

Personalised recommendations